Showing results (141-150 of 284) with videos related to

Sort By:
Pageof 29
Lancet (London, England)|April 16, 1994
Prospective study of endogenous tissue plasminogen activator and risk of strokeP M Ridker, C H Hennekens, M J Stampfer, et al.
Lancet (London, England)|May 8, 1993
Endogenous tissue-type plasminogen activator and risk of myocardial infarctionP M Ridker, D E Vaughan, M J Stampfer, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|November 1, 1993
A cross-sectional study of endogenous tissue plasminogen activator, total cholesterol, HDL cholesterol, and apolipoproteins A-I, A-II, and B-100P M Ridker, D E Vaughan, M J Stampfer, et al.
Annals of Internal Medicine|May 15, 1991
Low-dose aspirin therapy for chronic stable angina. A randomized, placebo-controlled clinical trialP M Ridker, J E Manson, J M Gaziano, et al.
The American Journal of Clinical Nutrition|October 1, 1996
Vitamin A status in acute exacerbations of cystic fibrosisC Duggan, A A Colin, A Agil, et al.
The American Journal of Cardiology|July 1, 1992
Comparison of delay times to hospital presentation for physicians and nonphysicians with acute myocardial infarctionP M Ridker, J E Manson, S Z Goldhaber, et al.
Clinical Biochemistry|February 1, 1986
Immunoturbidimetric assay of transferrin: effect of iron and need for serum blanksN Rifai, M E King, A Malekpour, et al.
Annals of Clinical and Laboratory Science|November 1, 1988
Review of serum lipids and apolipoproteins in risk-assessment of coronary heart diseaseN Rifai, J F Chapman, L M Silverman, et al.
Annals of Clinical and Laboratory Science|January 1, 1988
Cerebrospinal fluid and plasma apolipoproteins in patients with multiple sclerosisB B Gelman, N Rifai, R H Christenson, et al.
Clinical Chemistry|July 1, 1987
Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelinationN Rifai, R H Christenson, B B Gelman, et al.
Pageof 29